| Metric | შპს ნიუ ფარმა NEW PHARMA | სს საქართველოს ნავთობისა და გაზის კორპორაცია |
|---|---|---|
| Growth | ||
| Revenue | ₾883₾4.1m | ₾1.40bn₾1.35bn |
| Revenue growth | -100.0% | 3.8% |
| Profitability | ||
| EBITDA | -₾262k-₾476k | ₾130.7m₾61.3m |
| EBITDA margin | -29687.2%-11.6% | 9.3%4.5% |
| Net profit | -₾258k-₾726k | ₾50.1m₾109.1m |
| Net margin | -29249.2%-17.7% | 3.6%8.1% |
| Balance sheet | ||
| Total assets | ₾83k₾1.4m | ₾2.04bn₾2.26bn |
| Total equity | -₾780k-₾522k | ₾1.14bn₾1.08bn |
| ROE | — | 4.4%10.1% |